Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo
Authors
Keywords
Orthotopic tumor, NSG mouse, Antibody engineering, Carbonic anhydrase IX, Immunotherapy, Xenograft
Journal
Molecular Cancer
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-11
DOI
10.1186/s12943-015-0384-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Developments in Targeting Carbonic Anhydrase IX for Cancer Therapeutics
- (2015) Paul C. McDonald et al. Oncotarget
- Regression of established renal cell carcinoma in nude mice using lentivirus-transduced human T cells expressing a human anti-CAIX chimeric antigen receptor
- (2014) Agnes Shuk-Yee Lo et al. Molecular Therapy-Oncolytics
- Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics
- (2013) Alexandra Bailey et al. CANCER JOURNAL
- Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?
- (2013) Jens Bedke et al. Expert Review of Anticancer Therapy
- Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
- (2013) Jeannette Oosterwijk-Wakka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Human allograft rejection in humanized mice: a historical perspective
- (2012) Michael A Brehm et al. Cellular & Molecular Immunology
- Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
- (2012) A. McIntyre et al. CLINICAL CANCER RESEARCH
- Epidemiology, Aetiology, and Pathogenesis of Renal Cell Carcinoma
- (2012) Chris Protzel et al. EUROPEAN UROLOGY SUPPLEMENTS
- Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies
- (2012) T. Eisen et al. JNCI-Journal of the National Cancer Institute
- Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
- (2012) D.-K. Chang et al. MOLECULAR CANCER THERAPEUTICS
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
- (2012) S. Sivanand et al. Science Translational Medicine
- Immunological Heterogeneity of the RCC Microenvironment: Do Targeted Therapies Influence Immune Response?
- (2012) Axel Bex et al. Current Oncology Reports
- Inhibition of angiogenic and non-angiogenic targets by sorafenib in renal cell carcinoma (RCC) in a RCC xenograft model
- (2011) J S P Yuen et al. BRITISH JOURNAL OF CANCER
- Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX
- (2011) Margarita T. Murri-Plesko et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Epidemiology of Renal Cell Carcinoma
- (2011) Börje Ljungberg et al. EUROPEAN UROLOGY
- Carbonic Anhydrase IX Interacts with Bicarbonate Transporters in Lamellipodia and Increases Cell Migration via Its Catalytic Domain
- (2011) Eliska Svastova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients
- (2011) Chiara Grisanzio et al. JOURNAL OF PATHOLOGY
- Therapeutic Mechanism and Efficacy of the Antibody-Drug Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9
- (2011) H. M. Petrul et al. MOLECULAR CANCER THERAPEUTICS
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted Therapies in Metastatic Renal Cell Carcinoma: Overview of the Past Year
- (2011) Marine Gross-Goupil et al. Current Urology Reports
- Carbonic Anhydrase IX Expression in Renal Neoplasms
- (2010) Elizabeth M. Genega et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Carbonic anhydrase 9 in clear cell renal cell carcinoma: A marker for diagnosis, prognosis and treatment
- (2010) Jacques Tostain et al. EUROPEAN JOURNAL OF CANCER
- Development and Characterization of Clinically Relevant Tumor Models From Patients With Renal Cell Carcinoma
- (2010) Jose A. Karam et al. EUROPEAN UROLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
- (2010) Gregory L. Moore et al. mAbs
- Unique Biological Properties of Catalytic Domain Directed Human Anti-CAIX Antibodies Discovered through Phage-Display Technology
- (2010) Chen Xu et al. PLoS One
- A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
- (2010) M. Siebels et al. WORLD JOURNAL OF UROLOGY
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Vaccine Therapy in Patients with Renal Cell Carcinoma
- (2009) Hein Van Poppel et al. EUROPEAN UROLOGY
- The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths
- (2009) Pawel Swietach et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract
- (2009) L. HYRSL et al. NEOPLASMA
- Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice
- (2009) Q. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies
- (2008) Brian Shuch et al. BJU INTERNATIONAL
- Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pH
- (2008) J. Chiche et al. CANCER RESEARCH
- IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
- (2008) Nicholas D. Huntington et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
- A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene
- (2007) Marie King et al. CLINICAL IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now